Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3658)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 21, 2024 (publication date) through Oct 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yodoshi T. Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2024; 30(47): 5070-5075 [PMID: 39713163 DOI: 10.3748/wjg.v30.i47.5070] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v30/i47/5070.htm |
| Number | Citing Articles |
| 1 |
Olivia Chalifoux, Chloe Dagostino, Meijing Li, Stephanie Trezza, Cathryn Grayson, Mariana De Sa Tavares Russo, Daina Zofija Avizonis, Marek Michalak, Luis B. Agellon, Ryan J. Mailloux. Accumulation of succinate in the blood is a potential early indicator of metabolic dysfunction-associated steatotic liver disease (MASLD). Free Radical Biology and Medicine 2025; 241: 220 doi: 10.1016/j.freeradbiomed.2025.09.029
|
| 2 |
Laiba Shakeel, Ayesha Shaukat, Aymar Akilimali. Resmetirom: A Breakthrough in the Treatment of Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD). Health Science Reports 2025; 8(6) doi: 10.1002/hsr2.70920
|
| 3 |
Toshifumi Yodoshi. Machine learning fibrosis score for pediatric metabolic dysfunction-associated steatotic liver disease: Promising but premature. World Journal of Gastroenterology 2025; 31(36): 112217 doi: 10.3748/wjg.v31.i36.112217
|
| 4 |
Wenlong Lu, Jiahui Chen, Yonggang Guo, Zhan Wang, Weize Gao, Mingjun Liu. Fibroblast growth factor 19 in combination with liver fibrosis markers for non-invasive diagnosis of primary biliary cholangitis-associated cirrhosis. Clinica Chimica Acta 2026; 578: 120572 doi: 10.1016/j.cca.2025.120572
|